Explore the latest studies, experimental protocols, and scientific breakthroughs in apoptosis mechanisms
Explore how venetoclax, a BCL-2 inhibitor, shows promise in treating systemic chronic active Epstein-Barr virus disease by targeting infected cell survival mechanisms.